A Real-world Comparison of Infection Rate and Lymphocyte Counts Among Relapsing: Remitting Multiple Sclerosis Patients 50 Years or Older Treated with Subcutaneous Interferon Beta-1a Or Dimethyl Fumarate

B. Hayward, S. Cardoso, M. Grosso, S. Ansari, S. Napoli